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Abstract—PTB is subsidiary of B Company, a 
German health care supplier. Division AV of PTBB 
focuses on dialysis products and services. As 
Division AV started direct business in 2009, PTB 
expects it can be growth driver in 2011-2015. The 
research aims to recognize and create external 
opportunity in dialysis service provider, to explore 
internal resources, and to develop new business 
model of PTB dialysis center. Corporate 
entrepreneurship framework is applied to provide 
solution. The research methodology is qualitative 
approach by semi-structured interview. The 
discussion points are put business model framework 
and synthesized into PTBB dialysis service provider 
business model. The result shows key issues as 
external opportunity and internal resources. Kidney 
failure patient in Indonesia has huge potential 
because limited specialists and dialysis center 
capacity, expensive cost of treatment, and limited 
access to reimbursement scheme. Dialysis service is 
dominated by hospital-based dialysis unit. However, 
hospital-based dialysis unit capacity cannot fulfill 
demand of patients. Stand-alone dialysis clinic 
development is opportunity. However, it has 
challenges in complicated permit, higher investment, 
and lack of support in reimbursement. PTB has 
several internal resources that can be utilized. The 
proposed business model solution is standardized 
and interconnected dialysis clinic chain,. The dialysis 
clinic chain focus on JAMKESMAS/DA patients and 
untreated patients. To run this model, important 
activity is building relationship with coordinator, 
while important resources are standardized 
operation procedures and centralized IT. 
 
Keywords: Corporate Entrepreneurship, Business 
Model, Dialysis Center, Healthcare Service 
 
I.  INTRODUCTION 
 
Company B is a global leading health care 
supplier from Germany. The company was 
founded in 19th century and is still owned by 6th 
generation of founder family. It develops, 
manufactures, and commercializes over 30,000 
medical products and various services for 
worldwide health care market. Company B has 
four divisions that focus their products and 
services toward different medical fields, which 
are: Division HC, AE, OPM, and AV. PTB is 
Indonesian subsidiary of Company B and was 
founded in 2000. PTB divides its business work 
periods into of three: I (2000-2005), II (2006-
2010), III, (2011-2015). Division HC was the 
growth driver in period I and Division AE was 
the growth driver in period II. PTB plans 
Division AV to be growth driver in period III 
(2011-2015). 
 
Division AV focuses in medical products and 
services concerning extracorporeal blood 
treatment. This division provides dialysis centers 
and involved in dialysis and apheresis. 
Hemodialysis (HD) products and systems are the 
division’s core business. Division AV employs 
several business models, including: (1) Buy 
outright, which hospitals directly purchase the 
HD machines and consumables, (2) Pay-per-
treatment, which PTB places equipment and 
provides consumables, hospitals prepare space 
and run HD services, (3) Service provider, which  
hospitals prepare space, PTB set up the space 
and run the HD services. In Indonesia, Division 
AV started in 1996, before PTB became 
subsidiary in 2000. In 2005, PTB outsourced 
Division AV to sole distributor. In 2008, PTB 
decided to take back and run AV business by 
itself because of unsatisfied development in 
distributor. In 2011, the writer was appointed to 
develop AV business. PTB management expects 
AV Division can be the growth driver for PTB in 
period III. 
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To be growth driver, Division AV should have 
complete business model portfolio to 
accommodate faster growth than average PTB’s 
growth. In PTB, Division AV employs only Buy 
outright and Pay-per-treatment business model. 
Based on experience from other B’s subsidiary, 
Division AV needs to complete all business 
model portfolio, and specifically employs 
Service provider business model. At the moment, 
PTB does not employ Service provider model 
because PTB core business model (product 
marketing and sales) is different from Service 
provider model (healthcare service). On the other 
hand, dialysis service provider has various 
models among B’s subsidiaries. Each country 
has different opportunity and challenges in 
dialysis service market. The decision which 
service provider to be implemented in Indonesia 
needs comprehensive analysis based on local 
external opportunity and challenges, and also 
internal situation in particular country. Thus, this 
study aims to design new business model for 
PTB dialysis service provider, particularly to 
recognize and create external opportunity in 
dialysis service market, to identify internal 
resource of PTBB as parent company, and finally 
to design new business model for PTBB dialysis 
service provider. 
The study is limited to the preliminary business 
model study, since there are time constraint and 
complexity in business and market structure of 
dialysis service provider market. This restricted 
author to conduct a thorough and detailed study. 
 
II. BUSINESS ISSUE EXPLORATION 
 
Business sustainability depends on its ability to 
grow over the long term. Corporate 
entrepreneurship is a strategic answer for organic 
growth challenge. It is an important component 
of a well-balanced, long-term growth portfolio, 
together with company’s traditional innovation 
programs and new business development efforts, 
such as research and development, corporate 
venture capital, and acquisitions (Wolcott and 
Lippitz, 2010).  
 
Corporate entrepreneurship basically is new 
business design that largely about defining and 
implementing new and unfamiliar business 
models. IBM (2006) separates innovation types 
as products/services/markets innovation, 
operational innovation, and business model 
innovation. Magretta (2002) defines business 
models as ‘stories that explain how enterprises 
work’. Casadesus-Masanell and Ricart (2007) 
refers business model term to the logic of the 
firm, the way it operates and how it creates value 
for its stakeholders. Chesbrough (2007) 
described business model performs functions as 
creating value and capturing a portion of that 
value. 
 
A. Conceptual Framework 
Corporate entrepreneurship consists of 
opportunity recognition and/or creation, 
formation of resources, and value creation 
(Stevenson & Jarillo-Mossi, 1986) inside an 
established organization that is somewhat 
distinct from the parent company but that 
leverages and utilizes its resources (Wolcott & 
Lippitz, 2007), which is also a holistic innovation 
that develop all necessary components in 
designing new business model (Wolcott & 
Lippitz, 2010). This study uses these definitions 
as conceptual framework to design business 
model for PTB Service provider in Indonesia 
(see Figure 1). 
 
Osterwalder and Pigneur (2010) created business 
model canvas which visualize business model 
anatomy. According to them, business model 
canvas can be visualized into nine basic building 
blocks that show the logic of how a company 
intends to make money, which are: (1) Customer 
Segments, (2) Value Propositions, (3) Channels, 
(4) Customer Relationships, (5) Revenue 
Streams, (6) Key Resources, (7) Key Activities, 
(8) Key Partnerships, (9) Cost Structure. This 
study uses Business model canvas to analyze and 
synthesize business model for PTB Service 
provider in Indonesia. 
 
 
Parent Company
                                                           Leverage and Utilize               
Opportunity
Recognition‐Creation 
Internal Resource 
Identification/Formation
                                      
New Business Model Design
 
Figure 1. Conceptual Framework 
B. Method of Data Collection and Analysis 
This study need to answer three main questions, 
which are external opportunities, internal 
resources, and new business model design. To 
answer these questions, this study uses 
qualitative research methodology, which is in-
depth semi structured interview method to collect 
primary data. The interview method is to gather 
as much information and clarity of the situation 
and problem faced in the dialysis service 
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provider industry and internal resources of parent 
company.  
 
Major data are interpreted and divided into three 
main issues in dialysis service provider, which 
are: external opportunity, internal resources, and 
business model design. Together with interview 
data, literature review is enriched discussion. 
Further analysis of dialysis center comparison 
uses business model canvas to synthesize new 
business model. 
C. Analysis of Business Situation  
First analysis is regarding the external 
opportunity recognition-creation. External 
opportunity is classified into disease and patient 
trend, therapy and its challenges, local dialysis 
centers, regulation and reimbursement, and 
supplier of the industry.  
 
Second analysis is regarding the internal resource 
from Company B. Internal resource is classified 
into Division BA in global and regional Asia 
Pacific, PTB as local subsidiary, and local 
Division BA within PTB.  
 
Third analysis is regarding business model 
design. Business model design is classified using 
business model canvas into hospital-based 
dialysis unit analysis, stand-alone dialysis clinic 
analysis, and PTBB dialysis clinic chain 
synthesis.  
III. BUSINESS SOLUTION 
A. External Opportunity Recognition and 
Creation 
People life style and behavior change in food 
consumption pattern and physical activities 
influence the epidemiology of kidney disease or 
failure. Diabetes, high blood pressure, obesity, 
smoking, and aging lead to kidney failure. The 
most common forms of kidney failure are 
chronic kidney disease (CKD). The most severe 
stage of CKD is end-stage renal disease (ESRD), 
which means total loss of the kidney function.  
 
ESRD has shown an almost exponential growth 
in Indonesia. According to interview, the number 
of ESRD patient tends to increase over the year. 
Prodjosudjadi and Suhardjono (2009) reports that 
estimated, there are around 80.000 ESRD 
patients in Indonesia. Indonesian Renal Registry 
report 2012 report shows that the leading cause 
of ESRD in patients who underwent 
hemodialysis is chronic glomerulonephritis, 
diabetes mellitus and obstructive infective 
kidney diseases (PERNEFRI, 2012). 
 
Renal replacement therapy (RRT) is medical 
treatment for kidney failure patient and consists 
of hemodialysis (HD), peritoneal dialysis (PD), 
kidney transplant (TX). HD is the most therapy 
and become part of routine medical service for 
ESRD patients in Indonesia. Total 12,412 ESRD 
patients were dialyzed in 2006, which comprised 
only 15.5% of all ESRD patients requiring 
treatment. The reason of this low ratio of ESRD 
patient treated is because of high cost of RRT, 
lack of reimbursement scheme, low number of 
medical specialists in kidney disease, and less 
capacity of dialysis center. 
 
Indonesia Renal Registry (IRR) registered 204 
dialysis center in 2011. Among these centers, 
179 dialysis centers are hospital-based (92%) and 
only 14 stand-alone clinics (8%). Hospital-based 
dialysis center is more common than stand-alone 
clinics in Indonesia, which is reversed compared 
to global trend. The anomaly happens because 
hospital-based dialysis unit has less-restricted 
regulation, has complete supporting facilities, 
gets referral from kidney experts and other 
hospitals, and promotes dialysis units by 
advertising and symposium. However, hospital-
based dialysis center number is limited by the 
hospital number as well. This may prevent the 
capacity development of dialysis centers. 
 
Stand-alone dialysis clinics have limited service 
range that can do chronic dialysis for ESRD 
patients only. Low number of kidney experts is 
also potential problem for staff recruitment. Lack 
of medical standard operational procedure is 
another problem for treatment quality 
monitoring. In business perspective, limited and 
unclear government reimbursement scheme for 
clinics is the biggest problem, since most patients 
are poor and need government financial support 
to sustain their therapy. Last, in financial 
perspective, investment cost for stand-alone 
dialysis clinics is higher, because it needs basic 
requirement that hospital-based dialysis unit is 
supported by hospital. However, stand-alone 
dialysis clinic development may solve the 
problem low number of dialysis centers. This 
business opportunity has not been explored and 
exploited properly. 
 
Dialysis service provider is characterized by its 
high potential but cost competitive market. This 
market has high potential because estimated only 
15.5% ESRD patients are treated. However, 
renal replacement therapy is also cost 
competitive market because this long-term 
therapy becomes unbearable burden for patients 
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and limits their ability to do pay. Government 
health care coverage supports cost of renal 
replacement therapy for ESRD patients and 
burden government limited health care budget. 
Several ways have been done to reduce renal 
replacement therapy cost, which are reusing 
dialyzer for several time, using refurbished 
machine, operational cooperation scheme (or 
Pay-per-treatment).  
 
Dialysis center has capacity of patient treatment 
depends on number of HD machines and number 
of treatment shifts. Dialysis center normally 
works on two shifts, 6 working days per week, 
and minimum 4 HD machines. Therefore, one 
HD machines can do minimum 12 treatment per 
week, thus, a dialysis center with 4 machines can 
do 48 treatment per week. Since one patient 
needs minimal two therapy per week, therefore 
this dialysis center can serve up to 24 patients per 
week.  
 
Ministry of Health regulates standard of dialysis 
service in Indonesia in 2010 by Peraturan 
Menteri Kesehatan RI no. 
812/MENKES/PER/VII/2010. Hemodialysis 
services should be performed in health care 
facilities and should have official permit. The 
regulation includes also minimum standard, such 
as infrastructure space, hemodialysis equipments, 
and man power. However, socialization of this 
regulation was not clear and well-understood. 
Based on interview with external parties, 
socialization of this regulation was not clear and 
well-understood. Due to low socialization effort, 
in practice, minimum requirement of dialysis 
center has various and sometimes less than 
required by the new regulation. Recommendation 
from local PERNEFRI chief, nephrologist 
responsible for respective region, sometimes 
needs also long time to get. Therefore, local 
nephrologist support is crucial factors in the 
development of dialysis center. 
 
Health care reimbursement in Indonesia has 
various sources and  sometimes overlap each 
other. The reimbursement system includes: (1) 
central government sponsored community health 
insurance (JAMKESMAS), (2) provincial 
government sponsored health insurance 
(JAMKESDA); (3) government-owned health 
care insurance, which covers mostly civil 
servant, civil servant retiree, military/police 
retiree (ASKES); and (4) worker social security 
plan (JAMSOSTEK). According to the 
government, about 60 percent of total Indonesian 
people have been insured by the government 
health care coverage programs, comprising of 
76.5 million people covered by the 
JAMKESMAS; 31 million by the JAMKESDA; 
14 million by ASKES, and 3 million by 
JAMSOSTEK (Jamsos, 2011). In 2014, 
healthcare function of these reimbursement 
systems will be merged into BPJS Kesehatan 
(Badan Pelaksana Jaminan Sosial Kesehatan). 
ASKES will be the leader of BPJS Kesehatan 
merger process. Several uncertainties can affect 
BPJS Kesehatan reimbursement on current RRT 
reimbursement system, which are dialysis 
supplier restriction and unfavorable 
reimbursement system for stand-alone dialysis 
clinics. These uncertainties may affect RRT 
reimbursement scheme and need to be managed. 
 
Several supplier companies play as supplier 
company of hemodialysis product for dialysis 
center in Indonesia. These players and their 
business model are: (1) FMC, German company 
focusing on dialysis product-services and now 
market leader in Indonesia; (2) SRU, local 
company which has sole distributorship on 
Japanese brand of N; (3) MNJ, local company 
which has sole distributorship on Chinese brand 
of J; (4) MLH, local company which has sole 
distributorship on Sweden brand of G, (5) other 
small companies with several distributorship. 
 
In Indonesia, dialysis service providers are 
mostly hospitals, which employ hospital-based 
dialysis unit model. MLH is the only one known 
player owns and operates several dialysis centers. 
MLH owns and operates around 10 dialysis 
centers, mainly in Jakarta. MLH operates 
hospital’s or clinic’s dialysis centers by 
providing all investment and run operation. MLH 
get income from revenue sharing from the 
hospital. Patient pays HD service to hospital after 
the treatment, and hospital pays MLH in monthly 
basis. For business development, MLH offers 
cooperation with nephrologists or other parties, 
such as private investors. The cooperation 
scheme is nephrologists or other parties prepare 
spaces and MLH prepares initial investment, 
including renovation and equipments, and runs 
the dialysis operation. Both parties share revenue 
from the business income. MLH has cooperation 
with several local governments in JAMKESDA 
scheme, but does not have cooperation with 
JAMKESMAS, ASKES, and JAMSOSTEK, 
which serve broader patient base. This limits 
MLH in developing further business for broader 
patient base and outside Jabodetabek. 
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B. Internal Resources Analysis 
Company B traditionally focuses on innovative 
product manufacturing. Company B entered 
service provider business later, especially in 
dialysis center service provider. By entering 
service provider business, Company B did 
downstream vertical integration. It expanded its 
operation not only to produce dialysis product, 
but also go to downstream activities by providing 
dialysis service directly to ESRD patients. 
Company B owns and operates dialysis center in 
Europe, Asia, and South Africa. It owns total 180 
units of both stand-alone dialysis clinics and 
hospital-based dialysis unit in these regions. 
Company B manages also operational activities 
in some dialysis centers owned by other entities. 
Division BA global has developed some 
guidelines and tools for dialysis center operation. 
B’s subsidiaries can also share among each other 
regarding the development of dialysis centers. 
However, each country subsidiary should craft 
its own dialysis center development plan. The 
reason is that each country has different local 
regulation in setting up and operating dialysis 
center. Medical regulation is very strict in many 
countries due to its sensitivity in patient 
treatment. Important guidelines and tools in 
Division BA for dialysis center operation 
include: (1) Financial feasibility study guideline 
for dialysis center setup; (2) Standard operational 
procedures (SOP) guideline; (3) Training 
material for dialysis center staff; (4) Internal 
quality control team from Division BA global. 
 
Several B’s subsidiaries in Asia Pacific have 
started dialysis service provider business. 
Subsidiary in Philippines owns and operates 16 
dialysis centers in 2011. The dialysis service 
provider business was started in 1998 and 
expanded organically by setup new dialysis 
centers. Now, it plans to grow by acquisition of 
local dialysis chain. Subsidiary in Malaysia-
Singapore has 10 dialysis centers in 2011.  
 
It expands further organically by setup new 
dialysis centers and inorganically by acquisition 
of local dialysis chain. Subsidiary in India 
operates 18 dialysis centers in government 
hospitals under public-private partnership with 
local provincial government. It has responsibility 
to set up and operate all the dialysis centers in 
the 18 provincial government hospitals. On the 
other hand, provincial government insurance 
provides spaces-utilities, and pays per number 
dialysis treatments. To deal with distance barrier 
among dialysis centers, subsidiary in India 
develops information technology (IT) system for 
interconnection between dialysis centers. This IT 
provides monitoring system for dialysis chain 
management and provincial government. This 
solves common problem in developing country, 
such as India, that fraud and corruption of 
government fund and distrust among partners 
happen in massive scale.  
 
IT system provides transparency for partners and 
therefore prevents fraud and corruption. To get 
higher asset utilization, it generally runs dialysis 
centers in 3 or 4 treatment shifts per day, instead 
of regular 2 shift per  day in several centers. This 
bring down depreciation cost of equipment per 
treatment and therefore total cost per treatment. 
The service provider operation in Asia Pacific 
subsidiaries brings vast amount of practical 
knowledge in dialysis center operations. Dialysis 
center business models in Asia Pacific 
subsidiaries have many similarities, better than 
European or African models. Experiences and 
tools in these subsidiaries can be adapted to PTB 
business development of dialysis centers. 
 
PTB as the local B’s subsidiary is in the business 
of product marketing, sales, and distribution. 
PTB does also training and technical service as 
support in product business. As sole distributor 
of B products in Indonesia, PTB has good 
network in hospitals, doctors and nurses, and 
regulators, such as Ministry of Health and 
National Agency of Drug and Food Control. 
Customer and regulator perceive B brands as 
‘safety in healthcare’ concern brand and PTB as 
company that has good support in safety in 
healthcare training. B brand has good reputation 
brings advantages for local Division AV. As 
newly-developed business of PTB, Division AV 
is also perceived similar with B’s company-level 
strategy as safety in healthcare concerned 
company. Some products available in Indonesia 
from Division HC and AE can be used for the 
dialysis center. B’s product portfolio total 
offering from all division is an advantage in good 
perceived quality image and also in term of cost-
saving. Interdivisional transfer price is very 
efficient rather than purchase in the market.  
 
Local Division AV (PTB AV) has medium 
presence in dialysis market and the 4th largest 
player in Indonesia dialysis market. Key success 
factor of PTB is having good quality and high 
technology of HD machine and good company 
reputation in other divisions. PTB AV has 
limited activities in local user education, 
including exhibition in annual Indonesia Society 
of Nephrology congress. PTB AV offers buy 
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outright and PPT business schemes to the 
market. PTB is not provider partner of ASKES 
for HD product. However, B brand hemodialysis 
product is handled by one of exclusive HD 
provider partner of ASKES.  
 
PTB AV offers newest product portfolio, similar 
with global offers HD machine, for both Buy 
Outright and Pay-per treatment model. PTB AV 
offers complete portfolio for dialysis center 
investment products and high specification 
dialysis-related consumable products. PTB AV 
develop education support for nurse in dialysis 
service by Nurse Application Specialist. This AV 
nurse provides training to nurse regarding the 
dialysis knowledge and skill. The training 
program includes all operational process in the 
dialysis clinics, such as hemodialysis, infection 
control, patient safety, etc. 
 
C. New Business Model Design 
Dialysis service model in Indonesia can be 
divided into Hospital model and Clinic model. 
Hospital model describes the hospital-based 
dialysis unit, which means the dialysis service is 
done within hospital. Clinic model describes the 
stand-alone dialysis clinic, which means the 
dialysis service is done in independent clinics 
outside hospital. Both models are analyzed based 
on Business Model Canvas by Osterwalder and 
Pigneur (2010). Further, PTBB dialysis service 
provider business model (Chain model) is 
synthesized from both comparison and 
opportunity-challenge in the market. 
 
Hospital-based dialysis unit business model 
(Hospital model) focuses on wide customer 
segments, which are: long-term stable patient, 
instable critical patient, patients with various 
payment sources. This model can reach and serve 
wide customer segments as full-range medical 
service provider. Hospital model has broad 
channels, come from nephrologist or internal 
medicine doctors referral. For customer 
relationship, hospital may conduct general 
symposium regarding kidney health, dialysis 
nurse personal care, and patient gathering. 
Revenue stream in Hospital model comes from 
dialysis treatment fee by own-pocket, 
JAMKESMAS/DA, ASKES, insurance and 
additional pharmaceutical product sales.  
 
Key activities in Hospital model are 2 shifts 
dialysis treatment and equipment monitoring-
maintenance. Key resources are certified doctor-
nurses and dialysis equipment. Key partners for 
Hospital model are dialysis supplier company, 
ministry of health and PERNEFRI. Cost 
structure consists of equipment investment cost, 
operational cost, such as consumables, man 
power, and utility cost. Hospital has cost 
advantage due to wide economic of scope by 
providing full range of medical service. 
However, most hospital has less economy of 
scale due to less productivity of dialysis units. 
Most dialysis units run at average of four HD 
machines and two treatment shifts. Hospital 
cannot run more machines because resources 
competition among other internal services, 
especially in space and worker. Depreciation cost 
can be minimized if hospital utilizes more HD 
machines and more treatment shifts. 
 
Clinic model focuses on narrower customer 
segments, which are dialysis service for long-
term stable patients, patients with limited 
payment sources, such as personal source, 
limited JAMKESMAS/DA, and charity. To 
customer targeted segments, Clinic model offers 
value proposition of dialysis service for life-
extending care in ESRD patient, limited 
emergency facility and emergency transport to 
referral hospital. Clinic model offers also less 
risk in hospital associated infection (HAI). Clinic 
model employs limited channels, mainly from 
external doctors referral (nephrologist or internal 
medicine), walk in patients, community referral, 
and  low-cost social media.  
 
Clinics model uses dialysis nurse personal care 
as customer relationship that makes patient-nurse 
and among patients relationship has stronger 
bond. Revenue stream in Clinic Model comes 
from patients’ own-pocket which pay for dialysis 
treatment, and in limited clinics, 
JAMKESMAS/DA. Clinics gets revenue stream 
also from pharmaceutical product separated from 
dialysis treatment. Key activity in Clinic model 
is mainly also 2 shifts dialysis treatment and 
equipment monitoring-maintenance. Key 
resources are doctor and nurses which are 
certified from dialysis training hospital and good 
dialysis equipment are also important. Key 
partners for Clinic model are hospital referral, 
dialysis supplier company, ministry of health, 
and PERNEFRI.  
 
Cost structure in Clinic model consists of 
equipment investment cost, operational cost, 
such as consumables, man power, utility cost, 
and space cost. Clinic space can be taken from 
rental space or purchase building. Clinic does not 
get any cost advantage for economic of scope 
and economy of scale due to narrow customer 
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segment and has less productivity. Most stand-
alone dialysis clinics run at average of four HD 
machines and two treatment shifts. Clinic has 
less HD machine utilization machines because it 
has limited patients can be treated. Fix 
depreciation cost from investment can be 
minimized by utilizing more machine and more 
treatment shifts.  
 
PTB dialysis service provider business model 
(Chain model) is designed as growth driver for 
PTB in Period III (2011-2015). It considers 
analysis of external both Hospital model and 
Clinic model, and also internal parent company 
resources. Chain model reaches and serves only 
narrower customer segments, such as 
JAMKESMAS/DA patients, charity patients, and 
untreated patients. Untreated patients cannot 
finance hemodialysis treatment and comprise of 
84.5% of total ESRD patients. They have low 
income economy, less educated, and has no 
access to government reimbursement scheme. 
Chain model can also accommodate dialysis 
service for long-term stable patients. To 
customer targeted segments, Chain model offers 
value proposition of basic dialysis service, 
limited emergency facility, emergency transport 
to referral hospital. and less risk in hospital 
associated infection similar to Clinic model.  
 
Chain model develops several dialysis clinics 
network that is standardized and online-
connected, and administration support for 
reimbursement patient to help untreated patients 
to access reimbursement scheme. Chain model 
employs limited channels, from external doctors 
referral, walk in patients, or community referral. 
For promotion to general people, clinic 
advertises in social media. Chain model builds 
customer relationship with dialysis nurse 
personal care and patient community building. 
Revenue stream comes from JAMKESMAS/DA 
reimbursement and BPJS Kesehatan in 2014, 
charity fund donation and pharmaceutical 
product sales. Key activity in Chain model is 
three shifts basic dialysis treatment to increase 
productivity, equipment monitoring and 
maintenance, relationship building to 
JAMKESMAS/DA coordinator, and health care 
worker standardization in chain. SOP and 
training material from Global Division AV can 
be source of standardization and makes time 
efficiency in dialysis treatment, and therefore 
accommodate additional treatment shifts from 
two to three treatment shifts per day.  
 
Key resources are similar with Hospital and 
Clinic, but has additional standard operation 
procedure taken from subsidiary in India model 
for three treatment shifts per day and centralized 
Information Technology (IT) system adapted 
from India IT system. Centralized IT system can 
promote transparency and continuous 
monitoring. Key partners for Chain model are 
hospital referral, Ministry of Health, PERNEFRI, 
and referring doctors. Dialysis supplier is no 
longer needed because Chain model uses B 
products exclusively. Cost structure consists of 
equipment investment and operational cost. 
Chain model does not get any cost advantage due 
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to wide economic of scope. However, it gets 
economy of scale due higher productivity. 
Dialysis clinic in Chain model runs at average of 
8-10 HD machines and three treatment shifts. Fix 
depreciation cost per treatment is minimized by 
utilizing more machine and more treatment shifts 
(see Table 1). 
 
Hospital model domination over Clinic model in 
Indonesia happens because several factors, which 
are easier permit because needs only additional 
permit to add dialysis unit in hospital, favored by 
government health care reimbursement fund 
because of transparency and trust, and has better 
financial model. However, Hospital model has 
limitation for further growth, because of limited 
by hospital number, competition for internal 
hospital resources.  
 
A chain of healthcare facilities that specialized in 
dialysis service, such as shown in Chain model, 
will bring more benefits compared to Hospital 
and Clinic models. Compared to Hospital model, 
Chain model can scale up easily because of no 
limitation by hospital number and fight of 
resource allocation in internal hospital. 
Compared to Clinic model, Chain model brings 
efficiency in permit process, creates transparency 
with IT system, brings better financial-operation 
model and economic of scale.  
 
IV. CONCLUSION AND IMPLEMENTATION 
PLAN  
 
From the finding and discussion, final 
conclusions for dialysis service provider business 
model design of PTB Division AV are: external 
opportunities in dialysis service market in 
Indonesia are very huge, PTB AV has internal 
resources that can be used for supporting the 
dialysis service provider business model in this 
corporate entrepreneurship scheme, and 
proposed business model solution is dialysis 
clinic chain (Chain model), which consists of 
dialysis clinics network that standardized and 
interconnected.  
 
Based on analysis and recommended solution, 
several activities will be done to implement PTB 
Dialysis Chain business model, which are: 
develop dialysis clinic chain model feasibility 
studies, develop relationship with key partners, 
start pilot project of first dialysis clinic operation, 
scale up to five dialysis clinics operation within 
similar region and manage dialysis clinic chain.  
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